Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
LogicBio Therapeutics, Inc. (LOGC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/17/2022 |
4
| Kay Mark A (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 784,557 shares
@ $0
Disposed/sold 140,615 options to buy
@ $0.73, valued at
$102.6k
Disposed/sold 13,089 options to buy
@ $0.73, valued at
$9.6k
Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/17/2022 |
4
| Enyedy Mark J (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 2,921 shares
@ $0
Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/17/2022 |
4
| Nacht Mariana (Chief Scientific Officer) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 100,000 options to buy
@ $0.7, valued at
$70k
|
|
| 11/17/2022 |
4
| WYZGA MICHAEL S (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 3,141 shares
@ $0
Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/17/2022 |
4
| Chereau Frederic (President, CEO) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 253,811 shares
@ $0
Disposed/sold 547,000 options to buy
@ $0.73, valued at
$399.3k
Disposed/sold 328,000 options to buy
@ $0.7, valued at
$229.6k
|
|
| 11/17/2022 |
4
| MOSCICKI RICHARD A (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 3,916 shares
@ $0
Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/17/2022 |
4
| Goater Jeff (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/17/2022 |
4
| Karydas Daphne (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/17/2022 |
4
| Chen Leon (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 22,333 shares
@ $0
Disposed/sold 44,508 options to buy
@ $0.73, valued at
$32.5k
Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 11/17/2022 |
4
| Gruskin Daniel (Chief Medical Officer) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 3,331 shares
@ $0
Disposed/sold 140,000 options to buy
@ $0.7, valued at
$98k
|
|
| 11/17/2022 |
4
| Kahn Susan (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Disposed/sold 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 07/05/2022 |
4
| Karydas Daphne (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Kay Mark A (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 06/21/2022 |
4
| Kahn Susan (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $0.38, valued at
$4.8k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Paul Andrea (General Counsel and Secretary) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $0.7, valued at
$56k
|
|
| 03/03/2022 |
4
| Gruskin Daniel (Chief Medical Officer) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 140,000 options to buy
@ $0.7, valued at
$98k
|
|
| 03/03/2022 |
4
| Jones Cecilia (CFO) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 112,000 options to buy
@ $0.7, valued at
$78.4k
|
|
| 03/03/2022 |
4
| Nacht Mariana (Chief Scientific Officer) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.7, valued at
$70k
|
|
| 03/03/2022 |
4
| Chereau Frederic (President and Chief Executive) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 328,000 options to buy
@ $0.7, valued at
$229.6k
|
|
| 01/13/2022 |
4
| Jones Cecilia (CFO) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,175 shares
@ $2.01, valued at
$4.4k
Exercised 5,939 restricted stock units
@ $0 |
|
| 12/23/2021 |
4
| Kahn Susan (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.41, valued at
$60.3k
|
|
| 08/10/2021 |
4
| Gruskin Daniel (Chief Medical Officer) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Sold 1,467 shares
@ $4.35, valued at
$6.4k
Exercised 4,798 restricted stock units
@ $0 |
|
| 06/21/2021 |
4
| Kay Mark A (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 5,000 options to buy
@ $4.05, valued at
$20.3k
|
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Chen Leon (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $4.59, valued at
$57.4k
|
|
| 06/14/2021 |
4
| Karydas Daphne (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $4.59, valued at
$57.4k
|
|
| 06/14/2021 |
4
| Kay Mark A (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $4.59, valued at
$57.4k
|
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|